A gift to the Department of Surgery helps our physicians and scientists find new treatments and cures for serious diseases.
Maurice Galante, M.D., a legendary master surgeon at UCSF and renaissance man, died on February 5, 2013. His career is memorialized by the Maurice Galante Lecture Program and Maurice Galante Distinguished Professorship.
Dr. Jade Hiramoto is a vascular surgeon with expertise in both minimally invasive endovascular techniques as well as open surgical interventions. Her clinical areas of expertise include open and endovascular repair of thoracic and abdominal aortic aneurysms and dissections, carotid artery disease, renovascular disease, and lower extremity arterial and venous disorders.
Dr. Hiramoto earned her medical degree from the University of California, San Francisco School of Medicine. She completed her residency in general surgery, as well as fellowships in both interventional radiology and vascular surgery at the University of California San Francisco. She is an assistant professor of surgery at UCSF.
Dr. Hiramoto's research involves both clinical and translational research, with a special interest in the abnormal inflammatory response and kidney injury after complex endovascular aortic procedures. She is also interested in gender-based differences in the treatment and outcomes of vascular disease. Dr. Hiramoto is an investigator on several clinical trials, including the use of endovascular stent-grafts for treatment of abdominal and thoracic aortic aneurysms, the use of carotid stents for prevention of stroke, and the measurement of pressure changes in the aorta after placement of stent-grafts to treat aneurysms.
People with depression may have a higher risk of peripheral artery disease (PAD) -- narrowing of the arteries in the legs and pelvis -- according to researchers at UCSF, led by Marlene Grenon, M.D., C.M., of the UCSF Division of Vascular and Endovascular Surgery, and colleagues, including Jade S. Hiramoto, M.D., another UCSF vascular surgeon. The study included 1,024 men and women with coronary artery disease. At the recent American Heart Association's Arteriosclerosis Thrombosis and Vascular Biology scientific sessions, Dr. Grenon said the study demonstrated the importance of depression screening and treatment patients with PAD. The full findings are published in the Journal of the American Heart Association.